EDRH
TEVA icon

Edmond de Rothschild Holding’s Teva Pharmaceuticals TEVA Stock Holding History

Edmond de Rothschild Holding’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-8,845
Closed -$266K – 641
2026
Q1 		$266K Hold
8,845
– – ﹤0.01% 363
2025
Q4 		$276K Hold
8,845
– – ﹤0.01% 365
2025
Q3 		$179K Hold
8,845
– – ﹤0.01% 394
2025
Q2 		$148K Sell
8,845
-3,828
-30% -$61.8K ﹤0.01% 395
2025
Q1 		$195K Sell
12,673
-5,460
-30% -$97.5K ﹤0.01% 389
2024
Q4 		$400K Hold
18,133
– – 0.01% 352
2024
Q3 		$327K Sell
18,133
-6,362
-26% -$111K 0.01% 382
2024
Q2 		$398K Hold
24,495
– – 0.01% 367
2024
Q1 		$346K Buy
24,495
+947
+4% +$11.9K 0.01% 387
2023
Q4 		$246K Hold
23,548
– – ﹤0.01% 411
2023
Q3 		$240K Hold
23,548
– – ﹤0.01% 409
2023
Q2 		$177K Buy
23,548
+15,300
+185% +$124K ﹤0.01% 452
2023
Q1 		$73K Buy
8,248
+2,070
+34% +$20.5K ﹤0.01% 554
2022
Q4 		$56.3K Sell
6,178
-500
-7% -$4.36K ﹤0.01% 624
2022
Q3 		$54K Buy
6,678
+4,550
+214% +$40.2K ﹤0.01% 653
2022
Q2 		$16K Sell
2,128
-3,890
-65% -$33.9K ﹤0.01% 740
2022
Q1 		$57K Hold
6,018
– – ﹤0.01% 661
2021
Q4 		$48K Hold
6,018
– – ﹤0.01% 707
2021
Q3 		$58K Hold
6,018
– – ﹤0.01% 681
2021
Q2 		$60K Hold
6,018
– – ﹤0.01% 660
2021
Q1 		$69K Hold
6,018
– – ﹤0.01% 598
2020
Q4 		$58K Buy
6,018
+2,000
+50% +$19.2K ﹤0.01% 555
2020
Q3 		$36K Hold
4,018
– – ﹤0.01% 530
2020
Q2 		$50K Hold
4,018
– – ﹤0.01% 498
2020
Q1 		$36K Sell
4,018
-2,840
-41% -$29.1K ﹤0.01% 479
2019
Q4 		$67K Buy
6,858
+750
+12% +$6.7K ﹤0.01% 458
2019
Q3 		$42K Hold
6,108
– – ﹤0.01% 480
2019
Q2 		$57K Hold
6,108
– – ﹤0.01% 453
2019
Q1 		$96K Sell
6,108
-29,200
-83% -$515K ﹤0.01% 432
2018
Q4 		$544K Sell
35,308
-3,300
-9% -$67.7K 0.02% 303
2018
Q3 		$832K Sell
38,608
-1,000
-3% -$23.2K 0.02% 294
2018
Q2 		$963K Buy
39,608
+2,890
+8% +$58.9K 0.03% 274
2018
Q1 		$628K Sell
36,718
-800
-2% -$15.6K 0.02% 325
2017
Q4 		$711K Buy
37,518
+27,750
+284% +$417K 0.02% 312
2017
Q3 		$171K Buy
9,768
+2,140
+28% +$48.2K ﹤0.01% 528
2017
Q2 		$252K Sell
7,628
-1,535
-17% -$47.5K 0.01% 454
2017
Q1 		$298K Sell
9,163
-1,875
-17% -$64K 0.01% 439
2016
Q4 		$399K Buy
11,038
+1,520
+16% +$60.7K 0.01% 400
2016
Q3 		$447K Buy
9,518
+950
+11% +$49.6K 0.01% 399
2016
Q2 		$430K Sell
8,568
-100
-1% -$5.32K 0.01% 399
2016
Q1 		$467K Buy
8,668
+2,090
+32% +$123K 0.01% 367
2015
Q4 		$433K Sell
6,578
-12,990
-66% -$803K 0.01% 390
2015
Q3 		$1.1M Buy
19,568
+220
+1% +$14.3K 0.03% 270
2015
Q2 		$1.14M Buy
+19,348
New +$1.19M 0.02% 278

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Edmond de Rothschild Holding's TEVA Position: Q2 2026 in Review

Edmond de Rothschild Holding sold out of Teva Pharmaceuticals (TEVA) in Q2 2026, closing a stake of 8,845 shares — an estimated $266K sold.

Edmond de Rothschild Holding first reported a position in TEVA in Q2 2015 and held it in 44 quarters. The position peaked at $1.14M in Q2 2015. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Edmond de Rothschild Holding reported no remaining Teva Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Edmond de Rothschild Holding sold 8,845 Teva Pharmaceuticals shares in Q2 2026, an estimated $266K.
  • Edmond de Rothschild Holding first reported a position in Teva Pharmaceuticals in Q2 2015 and held it in 44 quarters.
  • Edmond de Rothschild Holding's Teva Pharmaceuticals position peaked at $1.14M in Q2 2015.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Edmond de Rothschild Holding's 13F filing for Q2 2026, filed 10 Aug 2026.